Stock of Privia Health Group Inc (PRVA) performance and profitability takes another direction

At the time of writing, Privia Health Group Inc [PRVA] stock is trading at $20.05, up 3.89%. In order to assess the stock’s recent performance, you can check whether its short-term value is rising or falling. The PRVA shares have gain 3.94% over the last week, with a monthly amount glided 11.64%, and seem to be holding up well over a long-time horizon.

3 Tiny Stocks Primed to Explode The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.

We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.

Click here for full details and to join for free
Sponsored

From an analyst’s perspective:

Privia Health Group Inc [NASDAQ: PRVA] stock has seen the most recent analyst activity on May 30, 2024, when Robert W. Baird initiated its Outperform rating and assigned the stock a price target of $23. Previously, Citigroup started tracking the stock with Buy rating on April 22, 2024, and set its price target to $25. On March 06, 2024, Barclays initiated with a Equal Weight rating and assigned a price target of $22 on the stock. BofA Securities downgraded its rating to a Neutral but $21 remained the price target by the analyst firm on February 22, 2024. JMP Securities started tracking with a Mkt Outperform rating for this stock on December 06, 2023, and assigned it a price target of $27. In a note dated June 13, 2023, Evercore ISI initiated an Outperform rating and provided a target price of $34 on this stock.

For the past year, the stock price of Privia Health Group Inc fluctuated between $15.92 and $27.34. Currently, Wall Street analysts expect the stock to reach $34.8 within the next 12 months. Privia Health Group Inc [NASDAQ: PRVA] shares were valued at $20.05 at the most recent close of the market. An investor can expect a potential return of 73.57% based on the average PRVA price forecast.

Analyzing the PRVA fundamentals

According to Privia Health Group Inc [NASDAQ:PRVA], the company’s sales were 1.70B for trailing twelve months, which represents an 2.17% jump. Gross Profit Margin for this corporation currently stands at 0.09% with Operating Profit Margin at 0.01%, Pretax Profit Margin comes in at 0.01%, and Net Profit Margin reading is 0.01%. To continue investigating profitability, this company’s Return on Assets is posted at 0.01, Equity is 0.03 and Total Capital is 0.02. Upon thorough examination of the company’s fundamental financial framework, it becomes apparent that the debt-to-equity ratio stands at 0.01.

Before buying any particular stock, readers tend to pay close attention to the indicators that support and create resistance. The company’s stock is currently sitting at 19.47 points at the first support level, and at 18.88 for the second support level. However, for the 1st resistance point, the stock is sitting at 20.39, and for the 2nd resistance point, it is at 20.72.

Ratios To Look Out For

It is important to note that Privia Health Group Inc [NASDAQ:PRVA] has a current ratio of 1.81. In addition, the Quick Ratio stands at 1.81 and the Cash Ratio stands at 0.9. Considering the valuation of this stock, the price to sales ratio is 1.41, the price to book ratio is 4.02 and price to earnings (TTM) ratio is 167.92.

Transactions by insiders

Recent insider trading involved Boehler Adam, Director, that happened on Jun 11 ’24 when 364.0 shares were purchased. Director, Boehler Adam completed a deal on May 29 ’24 to buy 5306.0 shares. Meanwhile, Director Boehler Adam bought 4280.0 shares on May 24 ’24.

Related Posts